Abstract
Background/Objectives
There is no specialist retinoblastoma (Rb) treatment centre in Afghanistan. We aimed to describe the first-year experience and outcome of referring Afghani children with Rb to Pakistan for treatment via the Afghanistan-Pakistan Rb “Silk-Road” referral pathway.
Methods
A 12-month prospective analysis (January 2023–January 2024) was conducted on children with suspected Rb presenting at National Organisation for Ophthalmic Rehabilitation (NOOR) eye care centres. Online consultations with specialists from the Rb-NET were used to confirm Rb diagnoses, and eligible patients were identified for referral to Rb treatment centres in Pakistan. Data on clinical presentation and outcomes were recorded using a structured Microsoft Excel spreadsheet, which was monitored by the entire team to ensure accuracy and completeness. The primary outcomes included successful transfer to Rb treatment centres in Pakistan and child survival at 1-year follow-up. Secondary outcomes focused on identifying barriers to successful patient transfer.
Results
Of the 23 children included in the study, 12/23 (52%) were referred due to leukocoria, 11/23 (48%) were female, 7/23 (30%) presented with bilateral Rb, and none had familial Rb. Overall, 5/23 (22%) children were diagnosed with extraocular disease, and 6/23 (26%) had distant metastases at the time of diagnosis. Only 9/23 (39%) children successfully reached Rb treatment centres in Pakistan. At the last follow-up, 5/23 (22%) children had died, 6/23 (26%) were confirmed alive, and 12/23 (52%) were lost to follow-up. The most common obstacles to patient transfer included difficulty crossing the Afghani/Pakistani border (12/23; 52%) and economic barriers (11/23; 48%) throughout the referral process.
Conclusions
This report highlights the immense difficulties in improving child survival from a treatable childhood cancer in a country with poor health care systems. The first-year experience of this referral pathway offers valuable lessons, which can guide the creation of a dedicated Rb treatment centre within Afghanistan.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
Data availability
Will be made available upon request from corresponding author.
References
Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Adamou Boubacar S, Ademola-Popoola DS, et al. Global Retinoblastoma Presentation and Analysis by National Income Level. JAMA Oncol. 2020;6:685–95.
Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Abdulrahaman AA, Abouelnaga S, et al. The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries. Lancet Glob Health. 2022;10:e1128–40.
Essar MY, Siddiqui A, Head MG. Infectious diseases in Afghanistan: Strategies for health system improvement. Health Sci Rep. 2023;6:e1775.
Afghanistan – Education Equity Profile for Adolescent Girls. United Nations Children’s Fund (UNICEF). 2019. Available from: https://www.unicef.org/rosa/media/5491/file/Afghanistan#:~:text=The%20majority%20of%20people%20in,disproportionately%20large%2C%20especially%20for%20girls.
Salem MR, Hegazy N, Eldeeb S, Shaguy JA, Nassery RM, Khawari A, et al. The current situation of health equity in underserved areas of Afghanistan. Front Public Health. 2024;12:1370500.
Islam Z, Rija A, Mohanan P, Qamar K, Jahangir K, Nawaz FA, et al. Afghanistan’s humanitarian crisis and its impacts on the mental health of healthcare workers during COVID-19. Global Ment Health. 2022;9:61–4.
Eye care facilities in Afghanistan. World Health Organization. 2025. Available from: https://www.emro.who.int/afg/programmes/eye-care.html#:~:text=Eye%20care%20facilities%20are%20mostly,and%20the%20Ministry%20of%20Higher
Eye Care. 2024. Available from: https://iam-afghanistan.org/c/eye-care/
Chang X, Pamjav H, Zhabagin M, Wen S. Editorial: The genetic history of human populations along the ancient silk road. Front Genet. 2023;14:1130104.
Retinoblastoma Silk Road Program: Referral Pathway from Afghanistan to Pakistan. 2023. Available from: https://www.rb-net-mdt.org/news/retinoblastoma-silk-road-program-referral-pathway-from-afghanistan-to-pakistan/
Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual, 8th ed. Springer; 2017.
Afghanistan Birth Rate 1950-2024. 2024. Available from: https://www.macrotrends.net/global-metrics/countries/AFG/afghanistan/birth-rate
Berry JL, Pike S, Rajagopalan A, Reid MW, Fabian ID, Afshar AR, et al. Retinoblastoma Outcomes in the Americas: a prospective analysis of 491 children with retinoblastoma from 23 American countries. Am J Ophthalmol. 2024:260:91–101.
Basij-Rasikh M, Dickey ES, Sharkey A. Primary healthcare system and provider responses to the Taliban takeover in Afghanistan. BMJ Glob Health. 2024;9:e013760.
Lamberti-Castronuovo A, Valente M, Bocchini F, Trentin M, Paschetto M, Bahdori GA, et al. Exploring barriers to access to care following the 2021 socio-political changes in Afghanistan: a qualitative study. Confl Health. 2024;18:36.
Yusuf MA, Hussain F, Sultan F, Badar F, Sullivan R. Cancer care in times of conflict: cross border care in Pakistan of patients from Afghanistan. Ecancermedicalscience. 2020;14:1018.
Tomar AS, Finger PT, Gallie B, Mallipatna A, Kivelä TT, Zhang C, et al. A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma. Ophthalmology. 2020;127:1719–32.
Author information
Authors and Affiliations
Contributions
MA and IDF were responsible for designing the study; all authors were responsible for overlooking the study, all authors were responsible for collecting the data; MA, AB and IDF analysed the data; MA wrote the preliminary draft; all authors reviewed and approval the final draft; IDF was responsible for overlooking the study.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Arazi, M., Kfir, J., Sediqi, S.M. et al. Afghanistan–Pakistan retinoblastoma “Silk Road” referral pathway. Eye 39, 2164–2168 (2025). https://doi.org/10.1038/s41433-025-03823-0
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-025-03823-0


